ACSL4 and type 2 diabetes mellitus: For example, Sun et al. reported that metformin (Met) treatment alleviated ferroptosis in β-cells in T2DM patients by increasing GPX4 expression and downregulating ACSL4 expression, whereas RSL3 injection significantly diminished the antiferroptotic effect of Met [84].